While IL-10 plays a pivotal role in tumor advancement, existing studies do not provide adequate evidence to substantiate an association between IL-10 concentrations in the peripheral blood of NPC patients and the intratumoral expression of IL-10. The gene discussed is IL10; the disease is nasopharyngeal carcinoma.